A Phase 1, Open-Label, Two-Period, Fixed-Sequence, Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam in Healthy Adult Subjects

Trial Profile

A Phase 1, Open-Label, Two-Period, Fixed-Sequence, Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Oct 2016

At a glance

  • Drugs Acebilustat (Primary)
  • Indications Cystic fibrosis
  • Focus Pharmacokinetics
  • Sponsors Celtaxsys
  • Most Recent Events

    • 28 Oct 2016 According to a Celtaxsys media release the result from this trial will be published in the journal Clinical and Translational Science (CTS), a publication of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
    • 09 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top